Not what AH trading is suggesting. _________________________________ Roche Board of Directors to sign off on a revised offer for the acquisition of Delcath Systems (DCTH) at tomorrows meeting in Basel. Our source on the ground in Basel tells us that the BOD has already reached a consensus and will validate that officially at the meeting. Our source tells us that the revised offer has been adjusted downward mirroring DCTH downward spiral but creating a bargain basement price for Roche! Shares of DCTH finished lower down almost 4% at the close of Tuesday's session. ________________________________ https://wallstreetwhispers.blogspot.com/2017/09/roche-and-delcath-systems-dcth.html
We know that, but you ever thought about what if RS just won't pass? What then? Go BK and let creditors take the treatment technology, patents and auction it ? I think not.